The prevention and treatment of various eye disorders, such as poor eye sight, is referred to as vision care. To restore eye sight, a variety of vision care items are employed, including prescription lenses, frames, contact lenses, non-prescription sunglasses, reading glasses, and contact lens solutions. Over the course of the projected period, rising cataract prevalence is anticipated to drive market expansion in North America. The market for eye care in North America is also anticipated to develop over the projected period as contact lens use among youngsters increases.

Market Dynamics

The market for vision care in North America is expected to grow as a result of an aging population and a rise in the proportion of residents who suffer from myopia, hyperopia, or other optical diseases. The increasing usage of eyeglasses as a fashion accessory is one of the major trends in vision care. Eye care, eye disorders, and vision care are all included in the broad topic of vision care. It is one of the fastest-growing sectors in the modern world. Untreated eye conditions such as glaucoma, corneal opacities, cataracts, diabetic retinopathy, trachoma, refractive error, and presbyopia affect the vision of millions of people today. These conditions and illnesses can all be treated with surgery, glasses, and contact lenses. The elderly population has revived the demand for vision care.

For example, in November 2021, the first U.S. FDA-approved autonomous artificial intelligence system was created for detecting diabetic retinopathy, the first FDA-approved gene therapy for an inherited disease targeted a retinal degeneration, and key discoveries in neural information processing were initially made in the visual system.

Key features of the study:

• This report provides in-depth analysis of the North America vision care market and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the North America vision care market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
• Key companies covered as a part of this study include Novartis AG, CooperVision, Inc., Johnson and Johnson Vision Care Inc., Valeant Pharmaceuticals International, Inc., SynergEyes, Inc., CarL ZEISS AG, Essilor International, Safilo Group S.P.A, Rodenstock and Luxottica.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The North America vision care market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America vision care market.

Detailed Segmentation:

• North America Vision Care Market, By Product Type:
  • Rx-Lenses
  • Frames
  • Contact Lenses
  • Non Rx-Sunglasses
  • Reading Glasses
  • Contact Lenses Solutions
• North America Vision Care Market, By Distribution Channel:
  • Retail Stores
  • E-Commerce
  • Clinics
  • Hospitals
• North America Vision Care Market, By Country :
  • U.S.
  • Canada
• Company Profiles
  • Novartis AG
  • CooperVision, Inc.
  • Johnson and Johnson Vision Care, Inc.
  • Bausch Health Companies Inc.
  • SynergEyes, Inc.
  • Carl ZEISS AG
  • Essilor Internationals
  • Safilo Group S.P.A
  • Rodenstock
  • Luxottica